Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Aug 28, 2018 at 9:20 AM EDT

Why Affimed Shares More Than Doubled

Affimed shares more than doubled early on Tuesday after it was announced that the firm entered into a strategic collaboration…

Chris Lange | Aug 27, 2018 at 11:55 AM EDT

Ra Medical Closes in on IPO

Commercial-stage medical device company Ra Medical Systems has amended its filing with the SEC for its initial public offering.

Chris Lange | Aug 27, 2018 at 10:05 AM EDT

Pfizer Slips Despite Strong Late-Stage Results

Pfizer shares slipped on Monday despite the company posting positive results from a late-stage tafamidis trial.

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Aug 27, 2018 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest in most of the…

Paul Ausick | Aug 24, 2018 at 1:15 PM EDT

The Safest Level of Drinking Alcohol: None

Results of a new study on the effects of alcohol use conclude that the safest level of drinking is none.…

Chris Lange | Aug 23, 2018 at 3:17 PM EDT

Kala Pharma Sees Unexpected Reaction to FDA Approval

Kala Pharmaceuticals shares dipped on Thursday after the U.S. Food and Drug Administration (FDA) announced that it had approved INVELTYS…

Chris Lange | Aug 22, 2018 at 12:35 PM EDT

Valeritas Gears Up For Secondary Offering

Diabetes-focused medtech company Valeritas has filed with the SEC regarding its initial public offering.

Trey Thoelcke | Aug 22, 2018 at 12:30 PM EDT

7 Biotech Stocks Insiders Are Loading Up On

La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Chris Lange | Aug 21, 2018 at 1:05 PM EDT

How the FDA Is Fighting the Nationwide EpiPen Shortage

The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school…

Chris Lange | Aug 21, 2018 at 11:45 AM EDT

Why Premier Is Tuesday’s Big Earnings Winner

Premier shares soared after it reported its fiscal fourth-quarter results before the markets opened on Tuesday.

Chris Lange | Aug 20, 2018 at 10:35 AM EDT

Why Amneal Is Monday’s Big Biopharma Winner

Amneal Pharma shares hit a post-IPO high in Monday’s session after the company announced a new licensing and supply agreement.

Jon C. Ogg | Aug 18, 2018 at 10:00 AM EDT

5 Speculative Biotech Analyst Picks With Upside Targets of 100% to 400%

24/7 Wall St. has identified several biotech analyst calls from Wall Street wherein the analysts are projecting upside of 100%…

Chris Lange | Aug 16, 2018 at 1:55 PM EDT

Are Teva and Mylan Entering an EpiPen Price War to Zero?

Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva…

1 … 122 123 124 125 126 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Affimed Shares More Than Doubled

Ra Medical Closes in on IPO

Pfizer Slips Despite Strong Late-Stage Results

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Short Sellers Run for Cover From Major Biotechs

The Safest Level of Drinking Alcohol: None

Kala Pharma Sees Unexpected Reaction to FDA Approval

Valeritas Gears Up For Secondary Offering

7 Biotech Stocks Insiders Are Loading Up On

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

How the FDA Is Fighting the Nationwide EpiPen Shortage

Why Premier Is Tuesday’s Big Earnings Winner

Why Amneal Is Monday’s Big Biopharma Winner

5 Speculative Biotech Analyst Picks With Upside Targets of 100% to 400%

Are Teva and Mylan Entering an EpiPen Price War to Zero?

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

‘Your Knowledge of Money and How It Works Is Nil’: Suze Orman to 62-Year-Old Who Nearly Locked His Wife Into $605 a Month

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

Health and Healthcare Articles

All Health and Healthcare Articles

Why Affimed Shares More Than Doubled

Ra Medical Closes in on IPO

Pfizer Slips Despite Strong Late-Stage Results

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Short Sellers Run for Cover From Major Biotechs

The Safest Level of Drinking Alcohol: None

Kala Pharma Sees Unexpected Reaction to FDA Approval

Valeritas Gears Up For Secondary Offering

7 Biotech Stocks Insiders Are Loading Up On

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

How the FDA Is Fighting the Nationwide EpiPen Shortage

Why Premier Is Tuesday’s Big Earnings Winner

Why Amneal Is Monday’s Big Biopharma Winner

5 Speculative Biotech Analyst Picks With Upside Targets of 100% to 400%

Are Teva and Mylan Entering an EpiPen Price War to Zero?

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

‘Your Knowledge of Money and How It Works Is Nil’: Suze Orman to 62-Year-Old Who Nearly Locked His Wife Into $605 a Month

Featured Reads

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.